Tactile Systems Technology, Inc. (NASDAQ: TCMD) Stock Competitors & Peer Comparison
See TCMD's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TCMD and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TCMD | $29.50 | +2.22% | 665.4M | 33.52 | $0.88 | N/A |
| ABT | $107.81 | -0.14% | 186.5B | 20.69 | $5.21 | +2.31% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $339.03 | +0.47% | 130B | 25.32 | $13.39 | +1.03% |
| MDT | $87.16 | +1.44% | 111.6B | 15.76 | $5.53 | +3.29% |
| BSX | $49.31 | +0.02% | 73.3B | 15.91 | $3.10 | N/A |
| EW | $89.72 | +0.45% | 51.7B | 33.23 | $2.70 | N/A |
| DXCM | $84.75 | +2.08% | 32B | 36.37 | $2.33 | N/A |
| RMD | $211.94 | -5.06% | 30.7B | 19.68 | $10.77 | +1.15% |
| PHG | $26.73 | +1.52% | 26.1B | 15.28 | $1.75 | +3.70% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
TCMD vs ABT Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ABT has a market cap of 186.5B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ABT trades at $107.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ABT's P/E ratio is 20.69. In terms of profitability, TCMD's ROE is +0.10%, compared to ABT's ROE of +0.11%. Regarding short-term risk, TCMD is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
TCMD vs BSX-PA Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, TCMD's ROE is +0.10%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, TCMD is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
TCMD vs SYK Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, SYK has a market cap of 130B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while SYK trades at $339.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas SYK's P/E ratio is 25.32. In terms of profitability, TCMD's ROE is +0.10%, compared to SYK's ROE of +0.16%. Regarding short-term risk, TCMD is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SYK's competition here
Medtronic plc (NYSE: MDT)
TCMD vs MDT Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, MDT has a market cap of 111.6B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while MDT trades at $87.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas MDT's P/E ratio is 15.76. In terms of profitability, TCMD's ROE is +0.10%, compared to MDT's ROE of +0.10%. Regarding short-term risk, TCMD is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
TCMD vs BSX Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, BSX has a market cap of 73.3B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while BSX trades at $49.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas BSX's P/E ratio is 15.91. In terms of profitability, TCMD's ROE is +0.10%, compared to BSX's ROE of +0.15%. Regarding short-term risk, TCMD is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
TCMD vs EW Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, EW has a market cap of 51.7B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while EW trades at $89.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas EW's P/E ratio is 33.23. In terms of profitability, TCMD's ROE is +0.10%, compared to EW's ROE of +0.10%. Regarding short-term risk, TCMD is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
TCMD vs DXCM Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, DXCM has a market cap of 32B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while DXCM trades at $84.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas DXCM's P/E ratio is 36.37. In terms of profitability, TCMD's ROE is +0.10%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, TCMD is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
TCMD vs RMD Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, RMD has a market cap of 30.7B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while RMD trades at $211.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas RMD's P/E ratio is 19.68. In terms of profitability, TCMD's ROE is +0.10%, compared to RMD's ROE of +0.24%. Regarding short-term risk, TCMD is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
TCMD vs PHG Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, PHG has a market cap of 26.1B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while PHG trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas PHG's P/E ratio is 15.28. In terms of profitability, TCMD's ROE is +0.10%, compared to PHG's ROE of +0.10%. Regarding short-term risk, TCMD is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
TCMD vs ZBH Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ZBH has a market cap of 18.7B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ZBH trades at $96.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ZBH's P/E ratio is 11.38. In terms of profitability, TCMD's ROE is +0.10%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, TCMD is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
TCMD vs ABMD Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ABMD's P/E ratio is 65.36. In terms of profitability, TCMD's ROE is +0.10%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, TCMD is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
TCMD vs PEN Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, PEN has a market cap of 12.8B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while PEN trades at $324.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas PEN's P/E ratio is 84.77. In terms of profitability, TCMD's ROE is +0.10%, compared to PEN's ROE of +0.11%. Regarding short-term risk, TCMD is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
TCMD vs SNN Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, SNN has a market cap of 12.6B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while SNN trades at $30.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas SNN's P/E ratio is 14.16. In terms of profitability, TCMD's ROE is +0.10%, compared to SNN's ROE of +0.12%. Regarding short-term risk, TCMD is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SNN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
TCMD vs SWAV Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas SWAV's P/E ratio is 78.76. In terms of profitability, TCMD's ROE is +0.10%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, TCMD is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
TCMD vs ALGN Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ALGN has a market cap of 12.4B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ALGN trades at $173.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ALGN's P/E ratio is 15.83. In terms of profitability, TCMD's ROE is +0.10%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, TCMD is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
TCMD vs GMED Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, GMED has a market cap of 11.1B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while GMED trades at $82.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas GMED's P/E ratio is 18.56. In terms of profitability, TCMD's ROE is +0.10%, compared to GMED's ROE of +0.12%. Regarding short-term risk, TCMD is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
TCMD vs GKOS Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, GKOS has a market cap of 10.6B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while GKOS trades at $180.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas GKOS's P/E ratio is -209.45. In terms of profitability, TCMD's ROE is +0.10%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, TCMD is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
TCMD vs PODD Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, PODD has a market cap of 9.8B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while PODD trades at $141.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas PODD's P/E ratio is 24.05. In terms of profitability, TCMD's ROE is +0.10%, compared to PODD's ROE of +0.27%. Regarding short-term risk, TCMD is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
TCMD vs BIO-B Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while BIO-B trades at $349.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas BIO-B's P/E ratio is 103.54. In terms of profitability, TCMD's ROE is +0.10%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, TCMD is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
TCMD vs BIO Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, BIO has a market cap of 9.5B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while BIO trades at $352.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas BIO's P/E ratio is 38.00. In terms of profitability, TCMD's ROE is +0.10%, compared to BIO's ROE of +0.03%. Regarding short-term risk, TCMD is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BIO's competition here
Masimo Corporation (NASDAQ: MASI)
TCMD vs MASI Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas MASI's P/E ratio is 44.43. In terms of profitability, TCMD's ROE is +0.10%, compared to MASI's ROE of +0.09%. Regarding short-term risk, TCMD is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
TCMD vs BRKR Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, BRKR has a market cap of 8.1B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while BRKR trades at $53.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas BRKR's P/E ratio is 26.84. In terms of profitability, TCMD's ROE is +0.10%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, TCMD is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BRKR's competition here
Inari Medical, Inc. (NASDAQ: NARI)
TCMD vs NARI Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas NARI's P/E ratio is -59.24. In terms of profitability, TCMD's ROE is +0.10%, compared to NARI's ROE of -0.00%. Regarding short-term risk, TCMD is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
TCMD vs ITGR Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ITGR trades at $125.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ITGR's P/E ratio is 19.72. In terms of profitability, TCMD's ROE is +0.10%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, TCMD is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
TCMD vs IRTC Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, IRTC has a market cap of 4.2B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while IRTC trades at $127.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas IRTC's P/E ratio is -199.75. In terms of profitability, TCMD's ROE is +0.10%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, TCMD is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check IRTC's competition here
LivaNova PLC (NASDAQ: LIVN)
TCMD vs LIVN Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while LIVN trades at $76.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas LIVN's P/E ratio is 18.10. In terms of profitability, TCMD's ROE is +0.10%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, TCMD is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check LIVN's competition here
Haemonetics Corporation (NYSE: HAE)
TCMD vs HAE Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, HAE has a market cap of 4B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while HAE trades at $87.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas HAE's P/E ratio is 17.54. In terms of profitability, TCMD's ROE is +0.10%, compared to HAE's ROE of +0.11%. Regarding short-term risk, TCMD is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check HAE's competition here
Axonics, Inc. (NASDAQ: AXNX)
TCMD vs AXNX Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas AXNX's P/E ratio is -709.80. In terms of profitability, TCMD's ROE is +0.10%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, TCMD is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
TCMD vs TMDX Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, TMDX has a market cap of 2.9B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while TMDX trades at $83.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas TMDX's P/E ratio is 42.58. In terms of profitability, TCMD's ROE is +0.10%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, TCMD is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
TCMD vs AXGN Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, AXGN has a market cap of 2.5B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while AXGN trades at $46.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas AXGN's P/E ratio is 122.18. In terms of profitability, TCMD's ROE is +0.10%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, TCMD is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
TCMD vs UFPT Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, UFPT has a market cap of 2.4B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while UFPT trades at $314.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas UFPT's P/E ratio is 32.07. In terms of profitability, TCMD's ROE is +0.10%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, TCMD is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
TCMD vs BFLY Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, BFLY has a market cap of 2.3B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while BFLY trades at $8.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas BFLY's P/E ratio is -36.77. In terms of profitability, TCMD's ROE is +0.10%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, TCMD is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
TCMD vs ESTA Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ESTA has a market cap of 2.3B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ESTA trades at $77.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ESTA's P/E ratio is -61.44. In terms of profitability, TCMD's ROE is +0.10%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, TCMD is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
TCMD vs NUVA Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas NUVA's P/E ratio is 75.00. In terms of profitability, TCMD's ROE is +0.10%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, TCMD is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
TCMD vs NVCR Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while NVCR trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas NVCR's P/E ratio is -10.71. In terms of profitability, TCMD's ROE is +0.10%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, TCMD is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
TCMD vs INSP Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while INSP trades at $60.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas INSP's P/E ratio is 26.51. In terms of profitability, TCMD's ROE is +0.10%, compared to INSP's ROE of +0.18%. Regarding short-term risk, TCMD is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
TCMD vs TNDM Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, TNDM has a market cap of 1.5B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while TNDM trades at $22.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas TNDM's P/E ratio is -20.35. In terms of profitability, TCMD's ROE is +0.10%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, TCMD is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check TNDM's competition here
Enovis Corporation (NYSE: ENOV)
TCMD vs ENOV Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ENOV trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ENOV's P/E ratio is 7.62. In terms of profitability, TCMD's ROE is +0.10%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, TCMD is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ENOV's competition here
CONMED Corporation (NYSE: CNMD)
TCMD vs CNMD Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while CNMD trades at $49.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas CNMD's P/E ratio is 10.78. In terms of profitability, TCMD's ROE is +0.10%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, TCMD is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
TCMD vs ATEC Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ATEC trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ATEC's P/E ratio is -155.17. In terms of profitability, TCMD's ROE is +0.10%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, TCMD is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ATEC's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
TCMD vs IART Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while IART trades at $17.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas IART's P/E ratio is 7.31. In terms of profitability, TCMD's ROE is +0.10%, compared to IART's ROE of -0.01%. Regarding short-term risk, TCMD is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
TCMD vs AORT Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, AORT has a market cap of 1.3B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while AORT trades at $27.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas AORT's P/E ratio is 45.28. In terms of profitability, TCMD's ROE is +0.10%, compared to AORT's ROE of -0.01%. Regarding short-term risk, TCMD is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
TCMD vs HSKA Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas HSKA's P/E ratio is -62.49. In terms of profitability, TCMD's ROE is +0.10%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, TCMD is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check HSKA's competition here
IRadimed Corporation (NASDAQ: IRMD)
TCMD vs IRMD Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while IRMD trades at $92.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas IRMD's P/E ratio is 46.48. In terms of profitability, TCMD's ROE is +0.10%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, TCMD is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check IRMD's competition here
Avanos Medical, Inc. (NYSE: AVNS)
TCMD vs AVNS Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas AVNS's P/E ratio is 27.77. In terms of profitability, TCMD's ROE is +0.10%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, TCMD is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check AVNS's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
TCMD vs PRCT Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while PRCT trades at $20.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas PRCT's P/E ratio is -10.52. In terms of profitability, TCMD's ROE is +0.10%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, TCMD is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check PRCT's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
TCMD vs SILK Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas SILK's P/E ratio is -18.96. In terms of profitability, TCMD's ROE is +0.10%, compared to SILK's ROE of -0.35%. Regarding short-term risk, TCMD is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SILK's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
TCMD vs LMRI Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while LMRI trades at $11.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas LMRI's P/E ratio is -22.53. In terms of profitability, TCMD's ROE is +0.10%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, TCMD is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check LMRI's competition here
Paragon 28, Inc. (NYSE: FNA)
TCMD vs FNA Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas FNA's P/E ratio is -19.83. In terms of profitability, TCMD's ROE is +0.10%, compared to FNA's ROE of -0.35%. Regarding short-term risk, TCMD is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
TCMD vs BVS Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, BVS has a market cap of 956.9M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while BVS trades at $14.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas BVS's P/E ratio is 18.59. In terms of profitability, TCMD's ROE is +0.10%, compared to BVS's ROE of +0.28%. Regarding short-term risk, TCMD is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BVS's competition here
InMode Ltd. (NASDAQ: INMD)
TCMD vs INMD Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, INMD has a market cap of 880M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while INMD trades at $15.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas INMD's P/E ratio is 10.63. In terms of profitability, TCMD's ROE is +0.10%, compared to INMD's ROE of +0.13%. Regarding short-term risk, TCMD is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check INMD's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
TCMD vs AVR Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, AVR has a market cap of 866.3M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while AVR trades at $8.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas AVR's P/E ratio is -4.00. In terms of profitability, TCMD's ROE is +0.10%, compared to AVR's ROE of -1.24%. Regarding short-term risk, TCMD is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
TCMD vs CSII Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas CSII's P/E ratio is -20.83. In terms of profitability, TCMD's ROE is +0.10%, compared to CSII's ROE of -0.14%. Regarding short-term risk, TCMD is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
TCMD vs SIBN Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, SIBN has a market cap of 825.3M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while SIBN trades at $18.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas SIBN's P/E ratio is -54.74. In terms of profitability, TCMD's ROE is +0.10%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, TCMD is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check SIBN's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
TCMD vs AHCO Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, AHCO has a market cap of 774.1M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while AHCO trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas AHCO's P/E ratio is 11.61. In terms of profitability, TCMD's ROE is +0.10%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, TCMD is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
TCMD vs SSII Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, SSII has a market cap of 754.5M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while SSII trades at $3.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas SSII's P/E ratio is -73.53. In terms of profitability, TCMD's ROE is +0.10%, compared to SSII's ROE of -0.23%. Regarding short-term risk, TCMD is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check SSII's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
TCMD vs BBNX Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, BBNX has a market cap of 715.3M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while BBNX trades at $15.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas BBNX's P/E ratio is -10.53. In terms of profitability, TCMD's ROE is +0.10%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, TCMD is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BBNX's competition here
CeriBell, Inc. (NASDAQ: CBLL)
TCMD vs CBLL Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, CBLL has a market cap of 713.7M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while CBLL trades at $18.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas CBLL's P/E ratio is -11.54. In terms of profitability, TCMD's ROE is +0.10%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, TCMD is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check CBLL's competition here
Surmodics, Inc. (NASDAQ: SRDX)
TCMD vs SRDX Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas SRDX's P/E ratio is -34.66. In terms of profitability, TCMD's ROE is +0.10%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, TCMD is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SRDX's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
TCMD vs BWAY Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, BWAY has a market cap of 608M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while BWAY trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas BWAY's P/E ratio is 39.38. In terms of profitability, TCMD's ROE is +0.10%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, TCMD is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BWAY's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
TCMD vs KIDS Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, KIDS has a market cap of 584.8M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while KIDS trades at $22.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas KIDS's P/E ratio is -19.30. In terms of profitability, TCMD's ROE is +0.10%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, TCMD is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
TCMD vs APEN Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas APEN's P/E ratio is -9.43. In terms of profitability, TCMD's ROE is +0.10%, compared to APEN's ROE of -0.85%. Regarding short-term risk, TCMD is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check APEN's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
TCMD vs CTKB Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, CTKB has a market cap of 542.4M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while CTKB trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas CTKB's P/E ratio is -22.25. In terms of profitability, TCMD's ROE is +0.10%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, TCMD is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check CTKB's competition here
ZimVie Inc. (NASDAQ: ZIMV)
TCMD vs ZIMV Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, TCMD's ROE is +0.10%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, TCMD is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ZIMV's competition here
Varex Imaging Corporation (NASDAQ: VREX)
TCMD vs VREX Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, VREX has a market cap of 522.5M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while VREX trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas VREX's P/E ratio is 13.06. In terms of profitability, TCMD's ROE is +0.10%, compared to VREX's ROE of -0.18%. Regarding short-term risk, TCMD is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check VREX's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
TCMD vs DCTH Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, DCTH has a market cap of 521.6M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while DCTH trades at $15.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas DCTH's P/E ratio is 1511.00. In terms of profitability, TCMD's ROE is +0.10%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, TCMD is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check DCTH's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
TCMD vs NPCE Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, NPCE has a market cap of 505.6M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while NPCE trades at $14.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas NPCE's P/E ratio is -25.57. In terms of profitability, TCMD's ROE is +0.10%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, TCMD is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check NPCE's competition here
Cerus Corporation (NASDAQ: CERS)
TCMD vs CERS Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, CERS has a market cap of 473.6M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while CERS trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas CERS's P/E ratio is -46.91. In terms of profitability, TCMD's ROE is +0.10%, compared to CERS's ROE of -0.10%. Regarding short-term risk, TCMD is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check CERS's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
TCMD vs CLPT Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, CLPT has a market cap of 426.2M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while CLPT trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas CLPT's P/E ratio is -12.04. In terms of profitability, TCMD's ROE is +0.10%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, TCMD is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check CLPT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
TCMD vs OFIX Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, OFIX has a market cap of 415.5M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while OFIX trades at $10.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas OFIX's P/E ratio is -13.43. In terms of profitability, TCMD's ROE is +0.10%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, TCMD is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check OFIX's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
TCMD vs SGHT Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, SGHT has a market cap of 406.4M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while SGHT trades at $7.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas SGHT's P/E ratio is -13.34. In terms of profitability, TCMD's ROE is +0.10%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, TCMD is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
TCMD vs CARL Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, CARL has a market cap of 375.7M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while CARL trades at $13.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas CARL's P/E ratio is -9.66. In terms of profitability, TCMD's ROE is +0.10%, compared to CARL's ROE of -0.38%. Regarding short-term risk, TCMD is more volatile compared to CARL. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
TCMD vs PACB Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, PACB has a market cap of 368.1M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while PACB trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas PACB's P/E ratio is -2.89. In terms of profitability, TCMD's ROE is +0.10%, compared to PACB's ROE of -49.62%. Regarding short-term risk, TCMD is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check PACB's competition here
CapsoVision, Inc. (NASDAQ: CV)
TCMD vs CV Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, CV has a market cap of 354.7M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while CV trades at $7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas CV's P/E ratio is -2.84. In terms of profitability, TCMD's ROE is +0.10%, compared to CV's ROE of +1.27%. Regarding short-term risk, TCMD is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check CV's competition here
Picard Medical, Inc. (AMEX: PMI)
TCMD vs PMI Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, PMI has a market cap of 349.2M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while PMI trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas PMI's P/E ratio is -2.83. In terms of profitability, TCMD's ROE is +0.10%, compared to PMI's ROE of +4.99%. Regarding short-term risk, TCMD is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check PMI's competition here
Electromed, Inc. (AMEX: ELMD)
TCMD vs ELMD Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ELMD has a market cap of 348.5M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ELMD trades at $42.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ELMD's P/E ratio is 35.97. In terms of profitability, TCMD's ROE is +0.10%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, TCMD is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ELMD's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
TCMD vs CATX Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, CATX has a market cap of 342.1M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while CATX trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas CATX's P/E ratio is -2.13. In terms of profitability, TCMD's ROE is +0.10%, compared to CATX's ROE of -0.42%. Regarding short-term risk, TCMD is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check CATX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
TCMD vs SMLR Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas SMLR's P/E ratio is 3.92. In terms of profitability, TCMD's ROE is +0.10%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, TCMD is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
TCMD vs TMCI Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, TMCI has a market cap of 308.8M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while TMCI trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas TMCI's P/E ratio is -5.06. In terms of profitability, TCMD's ROE is +0.10%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, TCMD is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check TMCI's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
TCMD vs SENS Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, SENS has a market cap of 293.4M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while SENS trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas SENS's P/E ratio is -3.51. In terms of profitability, TCMD's ROE is +0.10%, compared to SENS's ROE of -1.66%. Regarding short-term risk, TCMD is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check SENS's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
TCMD vs ANIK Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ANIK has a market cap of 286.7M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ANIK trades at $21.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ANIK's P/E ratio is 43.71. In terms of profitability, TCMD's ROE is +0.10%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, TCMD is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check ANIK's competition here
Profound Medical Corp. (NASDAQ: PROF)
TCMD vs PROF Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, PROF has a market cap of 269.3M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while PROF trades at $7.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas PROF's P/E ratio is -5.98. In terms of profitability, TCMD's ROE is +0.10%, compared to PROF's ROE of -0.56%. Regarding short-term risk, TCMD is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check PROF's competition here
RxSight, Inc. (NASDAQ: RXST)
TCMD vs RXST Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, RXST has a market cap of 259.1M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while RXST trades at $6.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas RXST's P/E ratio is -6.73. In terms of profitability, TCMD's ROE is +0.10%, compared to RXST's ROE of -0.17%. Regarding short-term risk, TCMD is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check RXST's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
TCMD vs MGRM Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas MGRM's P/E ratio is -12.00. In terms of profitability, TCMD's ROE is +0.10%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, TCMD is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check MGRM's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
TCMD vs FOCL Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, FOCL has a market cap of 233.1M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while FOCL trades at $6.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas FOCL's P/E ratio is -8.00. In terms of profitability, TCMD's ROE is +0.10%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, TCMD is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check FOCL's competition here
Nevro Corp. (NYSE: NVRO)
TCMD vs NVRO Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas NVRO's P/E ratio is -1.91. In terms of profitability, TCMD's ROE is +0.10%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, TCMD is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check NVRO's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
TCMD vs TLSI Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, TLSI has a market cap of 212.7M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while TLSI trades at $5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas TLSI's P/E ratio is -3.34. In terms of profitability, TCMD's ROE is +0.10%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, TCMD is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check TLSI's competition here
Avita Medical Inc. (NASDAQ: RCEL)
TCMD vs RCEL Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, RCEL has a market cap of 193M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while RCEL trades at $7.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas RCEL's P/E ratio is -4.95. In terms of profitability, TCMD's ROE is +0.10%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, TCMD is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
TCMD vs BSGM Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas BSGM's P/E ratio is -5.81. In terms of profitability, TCMD's ROE is +0.10%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, TCMD is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check BSGM's competition here
Quanterix Corporation (NASDAQ: QTRX)
TCMD vs QTRX Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, QTRX has a market cap of 189.8M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while QTRX trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas QTRX's P/E ratio is -2.52. In terms of profitability, TCMD's ROE is +0.10%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, TCMD is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check QTRX's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
TCMD vs MDGS Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas MDGS's P/E ratio is -0.27. In terms of profitability, TCMD's ROE is +0.10%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, TCMD is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
TCMD vs STIM Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, STIM has a market cap of 165.6M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while STIM trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas STIM's P/E ratio is -4.41. In terms of profitability, TCMD's ROE is +0.10%, compared to STIM's ROE of -1.65%. Regarding short-term risk, TCMD is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check STIM's competition here
Inogen, Inc. (NASDAQ: INGN)
TCMD vs INGN Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, INGN has a market cap of 163.8M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while INGN trades at $6.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas INGN's P/E ratio is -6.65. In terms of profitability, TCMD's ROE is +0.10%, compared to INGN's ROE of -0.13%. Regarding short-term risk, TCMD is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check INGN's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
TCMD vs QIPT Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas QIPT's P/E ratio is -15.87. In terms of profitability, TCMD's ROE is +0.10%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, TCMD is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check QIPT's competition here
iCAD, Inc. (NASDAQ: ICAD)
TCMD vs ICAD Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas ICAD's P/E ratio is -20.37. In terms of profitability, TCMD's ROE is +0.10%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, TCMD is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check ICAD's competition here
Owlet, Inc. (NYSE: OWLT)
TCMD vs OWLT Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, OWLT has a market cap of 99.9M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while OWLT trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas OWLT's P/E ratio is -39.43. In terms of profitability, TCMD's ROE is +0.10%, compared to OWLT's ROE of +11.36%. Regarding short-term risk, TCMD is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check OWLT's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
TCMD vs LUCD Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, LUCD has a market cap of 98.9M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while LUCD trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas LUCD's P/E ratio is -2.61. In terms of profitability, TCMD's ROE is +0.10%, compared to LUCD's ROE of -3.70%. Regarding short-term risk, TCMD is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check LUCD's competition here
Solana Company (NASDAQ: HSDT)
TCMD vs HSDT Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, HSDT has a market cap of 98.7M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while HSDT trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas HSDT's P/E ratio is -0.02. In terms of profitability, TCMD's ROE is +0.10%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, TCMD is more volatile compared to HSDT. This indicates higher risk in terms of short-term price fluctuations for TCMD.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
TCMD vs HJLI Comparison August 2026
Tactile Systems Technology, Inc. (NASDAQ: TCMD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TCMD stands at 665.4M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, TCMD is priced at $29.50 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TCMD currently has a P/E ratio of 33.52, whereas HJLI's P/E ratio is N/A. In terms of profitability, TCMD's ROE is +0.10%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, TCMD is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for TCMD.Check HJLI's competition here